Success Metrics

Clinical Success Rate
84.2%

Based on 16 completed trials

Completion Rate
84%(16/19)
Active Trials
3(10%)
Results Posted
25%(4 trials)
Terminated
3(10%)

Phase Distribution

Ph phase_2
1
3%
Ph phase_1
2
7%
Ph phase_4
5
17%
Ph phase_3
9
31%
Ph not_applicable
9
31%

Phase Distribution

2

Early Stage

1

Mid Stage

14

Late Stage

Phase Distribution26 total trials
Phase 1Safety & dosage
2(7.7%)
Phase 2Efficacy & side effects
1(3.8%)
Phase 3Large-scale testing
9(34.6%)
Phase 4Post-market surveillance
5(19.2%)
N/ANon-phased studies
9(34.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.2%

16 of 21 finished

Non-Completion Rate

23.8%

5 ended early

Currently Active

3

trials recruiting

Total Trials

29

all time

Status Distribution
Active(3)
Completed(16)
Terminated(5)
Other(5)

Detailed Status

Completed16
unknown4
Terminated3
Withdrawn2
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
29
Active
3
Success Rate
84.2%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (7.7%)
Phase 21 (3.8%)
Phase 39 (34.6%)
Phase 45 (19.2%)
N/A9 (34.6%)

Trials by Status

terminated310%
withdrawn27%
active_not_recruiting13%
recruiting27%
suspended13%
completed1655%
unknown414%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT04137692Not Applicable

Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome

Suspended
NCT06298643

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

Completed
NCT05405426Not Applicable

Trial of Indication-Based Transfusion of Red Blood Cells in ECMO

Active Not Recruiting
NCT05814094Not Applicable

Red Blood Cell Transfusion in ECMO - A Feasibility Trial

Recruiting
NCT06952361

Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients

Completed
NCT06560164Not Applicable

Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO

Recruiting
NCT04920045Not Applicable

A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge

Terminated
NCT02981407Phase 3

Myocardial Ischemia and Transfusion

Completed
NCT00202371Phase 4

Transfusion Effects in Myelodysplastic Patients: Limiting Exposure

Withdrawn
NCT00512577Phase 3

Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS)

Terminated
NCT01435746Not Applicable

Transfusion Requirements After Orthotopic Liver Transplantation

Withdrawn
NCT01393496Phase 4

Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants

Completed
NCT01167582Phase 3

Myocardial Ischemia and Transfusion Pilot

Completed
NCT02086773Phase 1

Red Cell Transfusion Goals in Patients With Acute Leukemias

Completed
NCT02465125Phase 2

The Transfusion Triggers in Vascular Surgery Trial

Completed
NCT00968227Phase 1

Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage

Completed
NCT03041974

Impact of Microparticles in Blood on Transfused Patient Outcomes

Completed
NCT01237639Phase 3

Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation

Completed
NCT00182390Phase 3

Premature Infants in Need of Transfusion (PINT)

Completed
NCT01895205Phase 3

Treatment of Women After Severe Postpartum Haemorrhage

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
29